These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19895215)

  • 1. Testing the susceptibility of human herpesviruses to antivirals.
    Agut H; Boutolleau D; Deback C; Bonnafous P; Gautheret-Dejean A
    Future Microbiol; 2009 Nov; 4(9):1111-23. PubMed ID: 19895215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms.
    Gilbert C; Bestman-Smith J; Boivin G
    Drug Resist Updat; 2002 Apr; 5(2):88-114. PubMed ID: 12135584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.
    De Clercq E; Naesens L; De Bolle L; Schols D; Zhang Y; Neyts J
    Rev Med Virol; 2001; 11(6):381-95. PubMed ID: 11747000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-nucleoside inhibitors of herpesviruses.
    Wathen MW
    Rev Med Virol; 2002; 12(3):167-78. PubMed ID: 11987142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.
    Hartline CB; Harden EA; Williams-Aziz SL; Kushner NL; Brideau RJ; Kern ER
    Antiviral Res; 2005 Feb; 65(2):97-105. PubMed ID: 15708636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets.
    Coen DM; Schaffer PA
    Nat Rev Drug Discov; 2003 Apr; 2(4):278-88. PubMed ID: 12669027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drugs active against herpesviruses].
    Fillet AM
    Rev Prat; 1997 Mar; 47(6):623-30. PubMed ID: 9183936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
    Sauerbrei A; Deinhardt S; Zell R; Wutzler P
    Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
    Saijo M; Suzutani T; Morikawa S; Kurane I
    Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
    Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
    Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpesviridae and novel inhibitors.
    Siakallis G; Spandidos DA; Sourvinos G
    Antivir Ther; 2009; 14(8):1051-64. PubMed ID: 20032535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update on new antiviral drug development for human herpesviruses].
    Inoue N; Hashimoto K; Fukuchi S
    Nihon Rinsho; 2012 Apr; 70(4):642-8. PubMed ID: 22568147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA polymerases of herpesviruses and their inhibitors.
    Piret J; Boivin G
    Enzymes; 2021; 50():79-132. PubMed ID: 34861944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.
    Field AK; Biron KK
    Clin Microbiol Rev; 1994 Jan; 7(1):1-13. PubMed ID: 8118786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance].
    Reusser P
    Schweiz Med Wochenschr; 1994 Jan; 124(4):152-8. PubMed ID: 8128197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Reusser P; Cordonnier C; Einsele H; Engelhard D; Link D; Locasciulli A; Ljungman P
    Bone Marrow Transplant; 1996 May; 17(5):813-7. PubMed ID: 8733703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 19. Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance.
    Pérez JL
    Microbiologia; 1997 Sep; 13(3):343-52. PubMed ID: 9353754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of new antivirals for herpesviruses.
    Eizuru Y
    Antivir Chem Chemother; 2003 Nov; 14(6):299-308. PubMed ID: 14968936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.